Our Services
Medical Information
Helpful Resources
Published on: 5/6/2026
Platelet Rich Plasma (PRP) therapy is an emerging treatment for Polycystic Ovary Syndrome (PCOS) that may improve ovarian function. Small clinical studies suggest PRP can support better follicle development, help restore regular menstrual cycles, and improve hormone balance in women with PCOS.
Before considering PRP, it's important to weigh several factors: treatment protocol details, potential risks and side effects, patient eligibility criteria, and overall cost. Below, you'll find detailed research findings, benefits, limitations, and practical next steps.
Because PCOS symptoms often overlap with other hormonal and reproductive conditions, understanding what's driving your symptoms is a critical first step before exploring treatments like PRP. Take a free, instant, online symptom check to help clarify your situation, identify possible causes, and guide your next conversation with a healthcare provider.
Reviewed for medical accuracy: 07/09/2026
Polycystic Ovary Syndrome (PCOS) affects up to 10% of women of reproductive age, causing irregular periods, excess androgens and cysts on the ovaries. While lifestyle changes, medications and assisted reproductive technologies remain the mainstay of treatment, researchers are exploring Platelet-Rich Plasma (PRP) therapy as an emerging option to improve ovarian function and hormone balance in PCOS.
Below, we'll explain:
Throughout, we'll use clear, straightforward language—no jargon or sugar-coating—so you can decide whether PRP for PCOS might be a path worth discussing with your doctor.
Platelet-Rich Plasma (PRP) is a concentration of your own blood's platelets suspended in a small volume of plasma. It's been used safely for years in orthopedics, dermatology and dentistry to speed healing and tissue regeneration.
How PRP is prepared:
Platelets release growth factors, cytokines and other proteins that can:
The hallmark of PCOS is hormonal imbalance: too much luteinizing hormone (LH) relative to follicle-stimulating hormone (FSH), high androgens (testosterone) and insulin resistance. This mix disrupts regular ovulation and can lead to small ovarian cysts.
PRP may help by:
While most ovarian PRP research focuses on poor ovarian reserve or premature ovarian insufficiency, pilot studies and case reports are exploring its role in PCOS.
Though still experimental, several small studies offer insight into PRP for PCOS:
Pilot trial in anovulatory PCOS patients (2021)
Case report: Improved egg quality
Preclinical studies
These studies are small and lack long-term follow-up. Larger randomized trials are underway to confirm safety and efficacy. For now, PRP for PCOS remains off-label and best viewed as an add-on in research or specialized clinics.
Women who've tried PRP for PCOS report:
Key takeaway: PRP targets the local ovarian environment rather than treating systemic insulin resistance or weight issues. It's not a standalone cure for PCOS but may complement existing therapies.
PRP is generally well tolerated because it's your own blood product. Still, there are potential downsides:
Before considering PRP for PCOS, ask your provider:
PRP may be an option if you:
PRP is less likely to help if:
If you're experiencing irregular periods, excess hair growth, acne, or other concerning symptoms, take a free AI symptom checker to evaluate your health and prepare meaningful questions before your next doctor's appointment.
Above all, stay proactive about your health. PCOS affects more than fertility: it carries risks for type 2 diabetes, cardiovascular disease and mental health challenges. Monitor blood sugar, blood pressure and emotional well-being as part of a comprehensive plan.
While PRP side effects are usually mild, you should contact a healthcare professional if you experience:
These signs could indicate a serious complication requiring prompt medical attention. Always speak to a doctor about any symptoms that worry you or seem life-threatening.
PRP for PCOS is an innovative, tissue-focused approach that shows promise in small studies. By delivering growth factors directly to the ovaries, PRP may help restore ovulation, regularize hormones and boost fertility outcomes. However, it remains experimental and should be considered only after standard treatments and in consultation with a specialist.
If you're noticing symptoms that may be related to hormonal imbalance or PCOS, use a free symptom assessment tool to gain clarity on your health and bring those insights to your reproductive endocrinologist for a personalized, evidence-based treatment plan. Always alert your doctor to any serious or life-threatening symptoms—your health and safety come first.
(References)
* Ghomi S, Khodamoradi M, Karimi S, Heidarpour M. Effectiveness of ovarian PRP in infertile women with diminished ovarian reserve and PCOS: a systematic review and meta-analysis. J Assist Reprod Genet. 2024 Feb;41(2):373-392. doi: 10.1007/s10815-023-02983-z. Epub 2023 Dec 7. PMID: 38060002; PMCID: PMC10850257.
* Li J, Tan S, Yang Y, Zhang Y, He Y, Long H. Therapeutic Potential of Platelet-Rich Plasma in Polycystic Ovary Syndrome: A Narrative Review. Reprod Sci. 2023 Dec;30(12):3561-3571. doi: 10.1007/s43031-023-00913-3. Epub 2023 Sep 16. PMID: 37718616; PMCID: PMC10842277.
* Altmae S, Salumets A, Tuve K, Juchno P, Reimand K, Šeikiene P, Saare M. Intraovarian injection of autologous platelet-rich plasma in women with poor ovarian response and polycystic ovary syndrome: A pilot study. Reprod Biol Endocrinol. 2023 May 10;21(1):50. doi: 10.1186/s12958-023-01083-w. PMID: 37165313; PMCID: PMC10170425.
* El-Dien H, Fares K, Abo El-Ghar M. Efficacy of Intraovarian Platelet-Rich Plasma (PRP) in Women with Polycystic Ovary Syndrome and Recurrent Implantation Failure: A Randomized Controlled Trial. Reprod Sci. 2024 Feb;31(2):595-603. doi: 10.1007/s43031-023-00922-2. Epub 2023 Sep 30. PMID: 37776404; PMCID: PMC10842299.
* El-Nashar MM, El-Kholy A, Attia HM, Amer E, El-Beshbishy O, Sharaf I. Effects of intra-ovarian platelet-rich plasma on ovarian function and hormonal profiles in women with polycystic ovary syndrome undergoing IVF: a randomized controlled trial. Arch Gynecol Obstet. 2023 May;307(5):1741-1748. doi: 10.1007/s00404-022-06834-4. Epub 2022 Oct 29. PMID: 36306066.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.